Taiwan FDA registration c8873c4a5dd063b1f9888450fbf708a5
Reva Steinberg CCX analyzer
TW: 露華史丹伯法CCX分析儀
Taiwan·Risk Class 2·NOVA BIOMEDICAL CORPORATION·Registered Mar 17, 2006 – Mar 17, 2026ExpiredRegistration details
- Analysis ID
- c8873c4a5dd063b1f9888450fbf708a5
- Customs Code
- DHA00601617100
Company information
- Manufacturer
- NOVA BIOMEDICAL CORPORATION
- Manufacturer Country
- United States
- Authorized Representative
- BEAM INTERNATIONAL INC.
Product details
- Intended Use
- Quantitative analysis of gas, electrolytes, heme, heme oxygen content, glucose, renal function, lactic acid and carbon monoxide content in blood.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1120 血內氣體(PCO2,PO2)及血液pH值試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Mar 17, 2006
- Expiry Date
- Mar 17, 2026
About this record
Access comprehensive regulatory information for Reva Steinberg CCX analyzer in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c8873c4a5dd063b1f9888450fbf708a5 and manufactured by NOVA BIOMEDICAL CORPORATION. The authorized representative in Taiwan is BEAM INTERNATIONAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices